Clinical Trial Update: Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG) [Phase 1, Phase 2]

View source ↗

Summary

An early-phase trial exploring stem cell therapy to improve myocardial function in patients undergoing coronary artery bypass grafting (CABG).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Disease, Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN